ReviewPublished 30 September 2026Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical applicationMan-Xi Jiang · Tao Jing · Huai L. Feng · Yan ZhuFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1921175
Original ResearchPublished 16 September 2026Overcoming delivery barriers of large all-in-one CRISPR/Cas9 plasmids using lysine-based lipid nanoparticlesWenhan Sung · Tianshu Li · Shinji TakeokaFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1888079
Original ResearchPublished 4 September 2026Synthesis, characterisation, and in vitro assessment of hyaluronic acid-coated solid lipid nanoparticles entrapping dexamethasone palmitate designed for intra-articular administrationJinxin Zhang · Rumi Khandelia · Bridget Hogg · Ahmad Z. Bahlool · Tom Hodgkinson · Sally-Ann Cryan · John O’Byrne · David J. BraydenFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1809275
CorrectionPublished 3 August 2026Correction: Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus ratsEBM Production OfficeExperimental Biology and Medicinedoi 10.3389/ebm.2026.10958
Hypothesis and TheoryPublished 24 July 2026The biological memory buffer hypothesis: can programmable nanocarriers shape cellular memory to improve the durability of mRNA vaccines and gene therapies?Okechukwu Paul-Chima Ugwu · Chinyere Nneoma Ugwu · Godson Emeka Anyanwu · Mariam Basajja · Maryann Chiamaka EbuohFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1902184
ReviewPublished 2 June 2026Nanomaterial-enabled RNA therapeutics: bridging delivery barriers to clinical translationKshipra Pandey · Sneha Jha · Loka Bikash Chaliha · Haren Gosai · Ritu PatelFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1860221
ReviewPublished 14 April 2026Advancements in polymer- and lipid-based nanoparticles for enhancing drug solubility, stability, and bioavailability: an integrative and forward-looking reviewRishika ChauhanFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1801422
Systematic ReviewPublished 1 April 2026Nanoparticle-mediated mRNA delivery for cancer, autoimmunity, and genetic diseases: a rapid reviewOkechukwu Paul-Chima Ugwu · Fabian C. Ogenyi · Mariam Basajja · Chinyere N. Ugwu · Mundu M. Mustafa · Michael Ben OkonFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1793322
Original ResearchPublished 13 January 2026Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cellsRiya Khetan · Weranga Rajapaksha · Bukuru D. Nturubika · Todd A. Gillam · Doug A. Brooks · Sanjay Garg · Anton Blencowe · Hugo Albrecht · Preethi EldiFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1727958
Original ResearchPublished 18 December 2025The influence of dioleoylphosphatidylcholine (DOPC) on the lipid sponge phase systemMarshall R. Machingauta · Aina McEvoy · Alma Karlsson · Justas Barauskas · Tommy Nylander · Jennifer GilbertFrontiers in Soft Matterdoi 10.3389/frsfm.2025.1708264
Impact JournalsPublished 7 October 2025Toward precision cardiovascular medicine: progressing basic and translational scienceRainer SchulzFrontiers in Sciencedoi 10.3389/fsci.2025.1659045
Drug DeliveryPublished 27 June 2025Advanced drug delivery systems for oral squamous cell carcinoma: a comprehensive review of nanotechnology-based and other innovative approachesAlain Herrada Céspedes · Montserrat Reyes · Javier O. MoralesFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1596964
